Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Stringer

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Inflammation|February 1, 1997
Tissue plasminogen activator (tPA) inhibits human neutrophil superoxide anion production in vitroK A Stringer, J Lindenfeld, A J Repine, et al.
Journal of Clinical Pharmacology|June 1, 1997
Pharmacokinetics of pirmenol enantiomers and pharmacodynamics of pirmenol racemate in patients with premature ventricular contractionsN Janiczek, D E Smith, T Chang, et al.
Drug Intelligence & Clinical Pharmacy|July 1, 1988
Verapamil preceded by calcium in supraventricular tachycardiaK A Stringer, P Hicks, S H Royal, et al.
Free Radical Biology & Medicine|July 17, 1998
Tissue plasminogen activator (tPA) inhibits interleukin-1 induced acute lung leakK A Stringer, B M Hybertson, O J Cho, et al.
Pharmacotherapy|January 1, 1992
Disposition of oral dipyridamole in patients undergoing thallium 201 myocardial imagingK A Stringer, J M Branconi, R Abadier, et al.
Journal of Clinical Pharmacology|August 1, 1989
The effect of verapamil on the pharmacokinetic disposition of theophylline in cigarette smokersA S Gin, K A Stringer, L S Welage, et al.
Journal of Clinical Pharmacology|July 1, 1991
The effect of pirmenol administration on the anti-coagulant activity of warfarinK A Stringer, D F Switzer, R Abadier, et al.
Journal of Clinical Pharmacology|December 1, 1988
Enhanced pirmenol elimination by rifampinK A Stringer, A B Cetnarowski, A Goldfarb, et al.
Pharmacotherapy|October 17, 2001
An institution-specific heparin titration nomogram: development, validation, and assessment of complianceD S Sherman, S H Clarke, J B Lefkowitz, et al.
Pharmacotherapy|August 6, 1998
Thrombolytic therapy for acute myocardial infarctionF L Meister, K A Stringer, S A Spinler, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Inflammation|February 1, 1997
Tissue plasminogen activator (tPA) inhibits human neutrophil superoxide anion production in vitroK A Stringer, J Lindenfeld, A J Repine, et al.
Journal of Clinical Pharmacology|June 1, 1997
Pharmacokinetics of pirmenol enantiomers and pharmacodynamics of pirmenol racemate in patients with premature ventricular contractionsN Janiczek, D E Smith, T Chang, et al.
Drug Intelligence & Clinical Pharmacy|July 1, 1988
Verapamil preceded by calcium in supraventricular tachycardiaK A Stringer, P Hicks, S H Royal, et al.
Free Radical Biology & Medicine|July 17, 1998
Tissue plasminogen activator (tPA) inhibits interleukin-1 induced acute lung leakK A Stringer, B M Hybertson, O J Cho, et al.
Pharmacotherapy|January 1, 1992
Disposition of oral dipyridamole in patients undergoing thallium 201 myocardial imagingK A Stringer, J M Branconi, R Abadier, et al.
Journal of Clinical Pharmacology|August 1, 1989
The effect of verapamil on the pharmacokinetic disposition of theophylline in cigarette smokersA S Gin, K A Stringer, L S Welage, et al.
Journal of Clinical Pharmacology|July 1, 1991
The effect of pirmenol administration on the anti-coagulant activity of warfarinK A Stringer, D F Switzer, R Abadier, et al.
Journal of Clinical Pharmacology|December 1, 1988
Enhanced pirmenol elimination by rifampinK A Stringer, A B Cetnarowski, A Goldfarb, et al.
Pharmacotherapy|October 17, 2001
An institution-specific heparin titration nomogram: development, validation, and assessment of complianceD S Sherman, S H Clarke, J B Lefkowitz, et al.
Pharmacotherapy|August 6, 1998
Thrombolytic therapy for acute myocardial infarctionF L Meister, K A Stringer, S A Spinler, et al.
Pageof 4